State Board of Administration of Florida Retirement System’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.4M Sell
85,419
-504
-0.6% -$74.8K 0.02% 480
2026
Q1
$11.3M Sell
85,923
-968
-1% -$128K 0.02% 524
2025
Q4
$12.3M Sell
86,891
-5,523
-6% -$800K 0.02% 511
2025
Q3
$13M Sell
92,414
-6,639
-7% -$900K 0.02% 506
2025
Q2
$12.4M Buy
99,053
+1,610
+2% +$185K 0.02% 519
2025
Q1
$10.8M Hold
97,443
0.02% 540
2024
Q4
$13.3M Sell
97,443
-90
-0.1% -$11.1K 0.03% 502
2024
Q3
$11.2M Sell
97,533
-5,800
-6% -$795K 0.02% 557
2024
Q2
$14.2M Sell
103,333
-6,113
-6% -$838K 0.03% 477
2024
Q1
$11.1M Buy
109,446
+2,153
+2% +$294K 0.03% 525
2023
Q4
$14.1M Buy
107,293
+96
+0.1% +$11.1K 0.03% 489
2023
Q3
$12.1M Buy
107,197
+150
+0.1% +$15.8K 0.03% 500
2023
Q2
$10.1M Sell
107,047
-2,399
-2% -$234K 0.02% 563
2023
Q1
$11.1M Hold
109,446
0.03% 535
2022
Q4
$13.1M Sell
109,446
-1,680
-2% -$197K 0.03% 480
2022
Q3
$11.8M Sell
111,126
-2,430
-2% -$247K 0.03% 505
2022
Q2
$11.1M Sell
113,556
-9,085
-7% -$838K 0.03% 534
2022
Q1
$11.5M Sell
122,641
-110
-0.1% -$9.32K 0.02% 578
2021
Q4
$10.5M Sell
122,751
-582
-0.5% -$53.5K 0.02% 651
2021
Q3
$11.8M Sell
123,333
-3,238
-3% -$306K 0.02% 594
2021
Q2
$12.3M Sell
126,571
-18,229
-13% -$1.75M 0.02% 604
2021
Q1
$14.1M Sell
144,800
-3,740
-3% -$392K 0.03% 545
2020
Q4
$14.2M Buy
148,540
+11,300
+8% +$1.09M 0.03% 531
2020
Q3
$13.2M Buy
137,240
+1,560
+1% +$180K 0.03% 493
2020
Q2
$16.6M Buy
135,680
+13,751
+11% +$1.52M 0.04% 412
2020
Q1
$10.6M Buy
121,929
+606
+0.5% +$59.3K 0.03% 464
2019
Q4
$13M Buy
121,323
+1,695
+1% +$177K 0.03% 505
2019
Q3
$10.8M Sell
119,628
-179
-0.1% -$16.7K 0.03% 543
2019
Q2
$10.1M Buy
119,807
+4,073
+4% +$334K 0.03% 586
2019
Q1
$10.2M Sell
115,734
-1,690
-1% -$141K 0.03% 570
2018
Q4
$8.38M Buy
117,424
+860
+0.7% +$82.4K 0.03% 585
2018
Q3
$14.3M Sell
116,564
-4,102
-3% -$465K 0.04% 477
2018
Q2
$11.9M Buy
120,666
+1,760
+1% +$158K 0.03% 527
2018
Q1
$9.86M Buy
118,906
+2,849
+2% +$241K 0.03% 579
2017
Q4
$9.01M Sell
116,057
-4,369
-4% -$298K 0.02% 621
2017
Q3
$7.38M Buy
120,426
+810
+0.7% +$42.7K 0.02% 680
2017
Q2
$5.5M Buy
119,616
+27,956
+30% +$1.36M 0.02% 777
2017
Q1
$3.97M Sell
91,660
-554
-0.6% -$23.7K 0.01% 854
2016
Q4
$3.57M Buy
92,214
+6,859
+8% +$310K 0.01% 880
2016
Q3
$4.32M Buy
85,355
+2,880
+3% +$143K 0.01% 814
2016
Q2
$3.75M Buy
82,475
+21,765
+36% +$1M 0.01% 851
2016
Q1
$2.4M Sell
60,710
-6,800
-10% -$270K 0.01% 945
2015
Q4
$3.82M Hold
67,510
0.01% 799
2015
Q3
$2.69M Hold
67,510
0.01% 930
2015
Q2
$3.22M Buy
67,510
+3,482
+5% +$148K 0.01% 929
2015
Q1
$2.54M Sell
64,028
-6,391
-9% -$229K 0.01% 1017
2014
Q4
$1.57M Sell
70,419
-22
-0% -$417 ﹤0.01% 1285
2014
Q3
$1.1M Hold
70,441
﹤0.01% 1480
2014
Q2
$1.04M Buy
70,441
+8,772
+14% +$124K ﹤0.01% 1588
2014
Q1
$993K Hold
61,669
﹤0.01% 1578
2013
Q4
$576K Hold
61,669
﹤0.01% 1947
2013
Q3
$698K Sell
61,669
-5,207
-8% -$71.6K ﹤0.01% 1814
2013
Q2
$895K Buy
+66,876
New +$822K ﹤0.01% 1612

Other funds holding NBIX

State Board of Administration of Florida Retirement System's NBIX Position: Q2 2026 in Review

State Board of Administration of Florida Retirement System reduced its Neurocrine Biosciences (NBIX) stake by 0.59% in Q2 2026, selling an estimated $74.8K and leaving 85,419 shares worth $14.4M. The position accounts for 0.02% of the portfolio, ranked #480.

State Board of Administration of Florida Retirement System first reported a position in NBIX in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.6M in Q2 2020. 432 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • State Board of Administration of Florida Retirement System held 85,419 shares of Neurocrine Biosciences worth $14.4M as of Q2 2026.
  • State Board of Administration of Florida Retirement System sold 504 Neurocrine Biosciences shares in Q2 2026, an estimated $74.8K.
  • Neurocrine Biosciences made up 0.02% of State Board of Administration of Florida Retirement System's portfolio in Q2 2026, its #480 holding.
  • State Board of Administration of Florida Retirement System first reported a position in Neurocrine Biosciences in Q2 2013 and has held it in 53 quarters since.
  • State Board of Administration of Florida Retirement System's Neurocrine Biosciences position peaked at $16.6M in Q2 2020.
  • 432 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2026, filed 10 Aug 2026.